Month: April 2020
Excerpt from the article: “Bodysphere announced today that it has begun distributing its 2-minute testing kit for diagnosing COVID-19 after receiving FDA emergency use authorization (EUA). The Los Angeles-based company’s two-minute testing kit uses antibodies in blood to test for current or past infection with a 91% clinical specificity rate and a 99% clinical sensitivity…
Read More
The Team at Zymewire took advantage of their unique position in the life sciences space to survey their client base regarding the impact of COVID-19 on their operations and business outlook. TrialStat had an opportunity to participate in the survey and the results are out. It’s resoundingly clear that the pandemic is impacting all aspects…
Read More
Researchers in the United States and China reported on Monday that they developed an artificial intelligence tool that is able to accurately predict which newly infected patients with the coronavirus go on to develop severe lung disease. Once deployed, the algorithm could assist doctors in making choices about where to prioritise care in resource-stretched healthcare…
Read More
Excerpt from the article: “It — somehow — hasn’t even been three months since the novel coronavirus was first identified, after dozens of people fell ill in Wuhan, China. But in that short time, scientists and researchers have worked at warp speed to understand the disease it causes: Already, nearly 30,000 studies have been conducted…
Read More- « Previous
- 1
- 2
- 3